Medication info
Acrab Tablets 60/20 mg

Acrab Tablets 60/20 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›150mg / 1 tabletAtorvastatin Calcium Trihydrate›10.4mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Orange round film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP*3]
Approval status
Active

MFDS item code 202003217 · Approved 2020.04.29 · Insurance code 641907630

Summary

Main use
Treatment of essential hypertension, improvement of hyperlipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, regardless of meals. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. This drug is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, fimasartan and atorvastatin. Patients receiving fimasartan and atorvastatin as separate products may switch to this drug (a combination product with the same amount of each active ingredient) for convenience of administration. ○ Fimasartan 1. Adults The recommended dose of this drug is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. (See section 9. Administration to elderly patients under Precautions for use.) 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this drug to patients with moderate ~ severe hepatic impairment (see sections 2. Patients in whom the drug must not be administered and 10. Administration to patients with hepatic impairment under Precautions for use). 5. Patients with decreased effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients in whom the drug should be administered with caution under Precautions for use.) ○ Atorvastatin Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Because the goal of treatment is to lower LDL cholesterol, use of LDL cholesterol is recommended when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, use total cholesterol levels to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. - Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. - Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of hyperlipidemia, and prevention of cardiovascular disease

  • Essential hypertension
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
View approved original text

This medication is used for patients who need to take Pimasartan and Atorvastatin together. Pimasartan is used to treat essential hypertension and helps lower blood pressure. Atorvastatin reduces the risk of myocardial infarction and stroke in adults with a high risk of coronary artery disease and in patients with type 2 diabetes. It also reduces the risk of myocardial infarction, stroke, angina, and hospitalization for heart failure in patients who already have heart disease. Additionally, Atorvastatin is used to treat hyperlipidemia, lowering cholesterol and triglycerides, while increasing good cholesterol (HDL). This medication is used for the prevention of hypertension and coronary artery disease, as well as the improvement of dyslipidemia.

How to take

Adult dose

Take 1 tablet once daily with water, regardless of meals. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. This drug is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, fimasartan and atorvastatin. Patients receiving fimasartan and atorvastatin as separate products may switch to this drug (a combination product with the same amount of each active ingredient) for convenience of administration. ○ Fimasartan 1. Adults The recommended dose of this drug is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. (See section 9. Administration to elderly patients under Precautions for use.) 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this drug to patients with moderate ~ severe hepatic impairment (see sections 2. Patients in whom the drug must not be administered and 10. Administration to patients with hepatic impairment under Precautions for use). 5. Patients with decreased effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients in whom the drug should be administered with caution under Precautions for use.) ○ Atorvastatin Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Because the goal of treatment is to lower LDL cholesterol, use of LDL cholesterol is recommended when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, use total cholesterol levels to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. - Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. - Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. One of the ingredients in this medication may cause adverse muscle reactions; if symptoms like muscle pain or myopathy occur, it should be discontinued and a doctor consulted. This medication is contraindicated for patients with certain liver diseases, kidney diseases, muscle disorders, and genetic problems such as lactose intolerance. Caution is advised for patients with a history of alcohol abuse or liver disease, the elderly, and patients with impaired kidney function when taking this medication; regular tests, including muscle-related examinations, may be required. During the initial phase of treatment or when increasing the dosage, blood pressure may drop too low, so symptoms should be closely monitored, and any occurrence of hypotension should be reported to a doctor immediately. This medication may increase blood potassium levels, so especially patients with heart failure or kidney dysfunction should have their potassium levels regularly monitored. There may be interactions if taken with other antihypertensive medications, certain diuretics, lithium, NSAIDs, etc.; patients should inform their doctor about any concurrent medications. Side effects such as headache, dizziness, fatigue, muscle pain, and digestive disturbances may occur during treatment, and patients should consult a doctor if these symptoms persist or worsen. Particularly, the risk of myopathy or rhabdomyolysis may increase when taken with other medications, so dose adjustments and monitoring are needed according to the doctor's instructions during polypharmacy. This medication should not be used during pregnancy and women of childbearing age should use appropriate contraceptive methods while taking it. Breastfeeding women should also consult a doctor whether to continue or stop breastfeeding as this medication may affect the baby. The safety of this medication in children and adolescents has not been established, so it is advisable not to use it in this population. Overdose may result in symptoms such as hypotension, palpitations, bradycardia; immediate medical attention should be sought if symptoms occur. This medication should be kept out of reach of children, stored in its original container, and transferred to other containers should be avoided.

Side effects

  • Headache
  • dizziness
  • increased serum creatine phosphokinase
  • abnormal liver enzyme levels
  • increased ALT
  • elevated serum lactate dehydrogenase
  • increased liver enzyme levels
  • hypokalemia
  • fatigue
  • edema
Show 340 more
  • myalgia
  • hypertension
  • extrasystole
  • syncope
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • epigastric pain
  • asthenia
  • foreign body sensation
  • elevated liver enzymes
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal rigidity
  • pruritus
  • localized urticaria
  • facial flushing
  • flushing
  • erectile dysfunction
  • acute pancreatitis
  • bowel obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • intracerebral hemorrhage
  • liver cancer
  • colon cancer
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of back pain
  • osteoarthritis
  • arthralgia
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary adenoma
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • ulcerative stomatitis
  • peptic ulcer
  • toothache
  • bloating
  • oral hemorrhage
  • dryness
  • colitis
  • colon polyp
  • gum pain
  • periodontitis
  • salivation
  • melena
  • gastroesophageal reflux
  • constipation
  • gastroenteritis
  • rash
  • onychomycosis
  • seborrheic dermatitis
  • skin diseases
  • keratosis
  • sweating
  • nail dystrophy
  • paronychia
  • contact dermatitis
  • hair loss
  • dermatitis
  • fracture
  • muscle weakness
  • tendonitis
  • osteomyelitis
  • rotator cuff syndrome
  • synovitis
  • sciatica
  • jaw pain
  • arthralgia
  • osteoporosis
  • muscle weakness
  • intracranial hemorrhage
  • arteriosclerosis
  • peripheral vascular disease
  • varicose veins
  • carpal tunnel syndrome
  • pulmonary tuberculosis
  • armpit pain
  • periorbital edema
  • allergy
  • chills
  • nasal polyps
  • peripheral edema
  • facial edema
  • fever
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • nosebleed
  • bronchitis
  • hypercholesterolemia
  • hypertriglyceridemia
  • thirst
  • worsening diabetes
  • calcinosis
  • hyponatremia
  • gout
  • eye pain
  • retinal disease
  • glaucoma
  • cataract
  • diplopia
  • floaters
  • uveitis
  • worsening chronic renal failure
  • cystitis
  • urinary tract infection
  • increased BUN
  • pyelonephritis
  • frequent urination
  • abscess
  • bacterial infection
  • genital herpes
  • cold sores
  • shingles
  • thrombocytosis
  • panic reaction
  • Alzheimer's disease
  • suicide attempt
  • anxiety
  • insomnia
  • depression
  • hyperthyroidism
  • hypothyroidism
  • increased TSH
  • atrial fibrillation
  • arrhythmia
  • tachycardia
  • myeloproliferative disease
  • worsening anemia
  • iron deficiency anemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • benign prostatic hyperplasia
  • scrotal pain
  • blood pressure fluctuations
  • fatty liver
  • lymphadenopathy
  • post-operative pain
  • back pain
  • limb pain
  • facial edema
  • malaise
  • chest pain
  • fever
  • oropharyngitis
  • hyperglycemia
  • weight gain
  • appetite loss
  • constipation
  • abdominal bloating
  • diarrhea
  • postnasal headache
  • nosebleed
  • nightmares
  • perceptual disturbance
  • sensory loss
  • distorted taste
  • memory loss
  • peripheral neuropathy
  • muscle cramping
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • vision impairment
  • tinnitus
  • hearing loss
  • urticaria
  • vascular edema
  • angioneurotic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • hepatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test values
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric-duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • acute respiratory distress
  • bronchitis
  • pneumonia
  • dyspnea
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • bronchitis
  • sensory abnormality
  • dizziness
  • photosensitivity reaction
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • hypertonia
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia
  • contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical secretions
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • malaise
  • vasomotor edema
  • chest pain
  • angina
  • facial swelling
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive error
  • subconjunctival hemorrhage
  • hearing loss
  • hallucination
  • taste loss
  • taste distortion
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • increased ACTH
  • decreased aldosterone
  • cerebral infarction
  • palpitations
  • tachycardia
  • positive urinary leukocytes

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

Orange round film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.